indirubin has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hoda, N; Maqbool, M; Mobashir, M | 1 |
| Alam, MS; Hamid, H; Khan, I; Tantray, MA | 1 |
| Ahmad, SS; Almalki, AS; Khalid, M; Khan, H | 1 |
| Dubbs, JM; Loprasert, S; Mongkolsuk, S; Sallabhan, R; Wongsaroj, L | 1 |
| Eisenbrand, G; Hippe, F; Jakobs, S; Muehlbeyer, S | 1 |
| Bibb, JA; Biernat, J; Eisenbrand, G; Garnier, M; Greengard, P; Hoessel, R; Leclerc, S; Mandelkow, EM; Marko, D; Meijer, L; Snyder, GL; Wu, YZ | 1 |
3 review(s) available for indirubin and Alzheimer Disease
| Article | Year |
|---|---|
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Clinical Trials as Topic; Diabetes Mellitus; Drug Discovery; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Neoplasms; Patents as Topic; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2017 |
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.
Topics: Adenosine Triphosphate; Alzheimer Disease; Antibiotics, Antineoplastic; Cell Cycle; Cyclin-Dependent Kinases; Diabetes Mellitus; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Medicine, Chinese Traditional; Structure-Activity Relationship | 2004 |
3 other study(ies) available for indirubin and Alzheimer Disease
| Article | Year |
|---|---|
Emetine and Indirubin- 3- monoxime interaction with human brain acetylcholinesterase: A computational and statistical analysis.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Brain; Catalytic Domain; Cholinesterase Inhibitors; Emetine; Humans; Indoles; Ligands; Molecular Docking Simulation | 2022 |
Cloning of Toluene 4-Monooxygenase Genes and Application of Two-Phase System to the Production of the Anticancer Agent, Indirubin.
Topics: Alzheimer Disease; Antibiotics, Antineoplastic; Bacterial Proteins; Cloning, Molecular; Escherichia coli; Humans; Indoles; Leukemia, Myeloid; Oxygenases; Pseudomonas | 2015 |
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Topics: Adenosine Triphosphate; Alkaloids; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Calcium-Calmodulin-Dependent Protein Kinases; CDC2 Protein Kinase; Cyclin B; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Dopamine and cAMP-Regulated Phosphoprotein 32; Drugs, Chinese Herbal; Enzyme Inhibitors; Flavonoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Indoles; Inhibitory Concentration 50; Mice; Molecular Structure; Neostriatum; Nerve Tissue Proteins; Phosphoproteins; Phosphorylation; Phosphothreonine; Piperidines; Staurosporine; tau Proteins | 2001 |